STRATEC Biomedical AG / Key word(s): AGM/EGM
STRATEC Annual General Meeting: Shareholders elect new Supervisory Board and approve dividend increase
Birkenfeld, June 18, 2014
At today's Annual General Meeting in Pforzheim, the shareholders of STRATEC Biomedical AG (Frankfurt: SBS; Prime Standard, TecDAX) approved all of the agenda items put to the vote with large majorities in each case.
Prof. Dr. Stefanie Remmele, Landshut, Professor for medical engineering at the Hochschule Landshut - University of Applied Sciences, was newly elected to the three-member Supervisory Board and thus succeeds Prof. Dr. Hugo Hämmerle. The previous Supervisory Board Chairman, Fred K. Brückner, and the previous Deputy Supervisory Board Chairman, Wolfgang Wehmeyer, stood for re-election and were once again elected to the supervisory body by the Annual General Meeting.
STRATEC is distributing a dividend of EUR 0.60 per share to its shareholders for the 2013 financial year (previous year: EUR 0.56). The distribution total amounts to EUR 7.1 million and will be paid to shareholders via their depository banks from June 20, 2014. The dividend has thus been increased for the tenth year in succession since the initiation of dividend payments in 2004.
Further information about the Annual General Meeting can be found on the company's website at www.stratec.com/agm.
Further information can be obtained from:
End of Corporate News
18.06.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
|Company:||STRATEC Biomedical AG|
|Phone:||+49 (0)7082 7916 0|
|Fax:||+49 (0)7082 7916 999|
|Listed:||Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart|
|End of News||DGAP News-Service|